Compare ABSI & PMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABSI | PMTS |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 192.1M |
| IPO Year | 2021 | 2015 |
| Metric | ABSI | PMTS |
|---|---|---|
| Price | $6.68 | $19.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $6.96 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 4.5M | 42.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.64 | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | $4,534,000.00 | ★ $312,189,000.00 |
| Revenue This Year | $215.96 | $9.95 |
| Revenue Next Year | $319.10 | $10.02 |
| P/E Ratio | ★ N/A | $111.29 |
| Revenue Growth | N/A | ★ 12.27 |
| 52 Week Low | $2.24 | $10.81 |
| 52 Week High | $7.39 | $25.37 |
| Indicator | ABSI | PMTS |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 64.45 |
| Support Level | $2.55 | $13.10 |
| Resistance Level | $7.06 | $19.52 |
| Average True Range (ATR) | 0.73 | 0.99 |
| MACD | -0.01 | 0.24 |
| Stochastic Oscillator | 69.70 | 93.44 |
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.